GAP

Pharmagap Inc. (GAP)

Pharmagap Inc.

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:GAP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2013/05/07	23 : 26	PR Newswire (Canada)	PharmaGap Notified of Cease Trade Order	TSXV:GAP	Pharmagap Inc.
2013/05/07	03 : 47	PR Newswire (Canada)	TSX Venture Exchange Cease Trade Order	TSXV:GAP	Pharmagap Inc.
2013/05/06	21 : 20	PR Newswire (Canada)	IIROC Trading Halt - GAP	TSXV:GAP	Pharmagap Inc.
2013/05/06	21 : 20	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GAP	TSXV:GAP	Pharmagap Inc.
2013/02/06	22 : 00	PR Newswire (Canada)	PharmaGap Receives Notice of Pending Transfer to NEX Exchange	TSXV:GAP	Pharmagap Inc.
2013/02/05	01 : 11	PR Newswire (Canada)	L’OCRCVM permet la reprise de la négociation - GAP	TSXV:GAP	Pharmagap Inc.
2013/02/05	01 : 11	PR Newswire (Canada)	IIROC Trading Resumption - GAP	TSXV:GAP	Pharmagap Inc.
2013/02/05	00 : 32	PR Newswire (Canada)	PharmaGap Provides Update on Status	TSXV:GAP	Pharmagap Inc.
2013/02/04	23 : 11	PR Newswire (Canada)	IIROC Trading Halt - GAP	TSXV:GAP	Pharmagap Inc.
2013/02/04	23 : 11	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GAP	TSXV:GAP	Pharmagap Inc.
2012/08/02	20 : 03	PR Newswire (Canada)	PharmaGap Shareholders Approve License to Clinical Value Corporation at Annual General Meeting	TSXV:GAP	Pharmagap Inc.
2012/07/05	21 : 00	PR Newswire (Canada)	PharmaGap Receives Independent Value Opinion and Support of Independent Committee for Proposed License to Clinical Value Corpor	TSXV:GAP	Pharmagap Inc.
2012/06/05	21 : 30	PR Newswire (Canada)	PharmaGap Updates Lead Drug Status and Potential Sale	TSXV:GAP	Pharmagap Inc.
2012/05/24	21 : 30	PR Newswire (Canada)	PharmaGap announces conditional approval to license its lead drug and related intellectual property	TSXV:GAP	Pharmagap Inc.
2012/01/21	05 : 19	Marketwired Canada	PharmaGap Completes $231,000 Private Placement	TSXV:GAP	Pharmagap Inc.
2012/01/12	05 : 21	Marketwired Canada	PharmaGap Completes $70,774 Private Placement	TSXV:GAP	Pharmagap Inc.
2011/12/21	21 : 00	Marketwired Canada	PharmaGap Completes In Vivo Study Protocol in Ovarian Cancer	TSXV:GAP	Pharmagap Inc.
2011/12/05	21 : 00	Marketwired Canada	PharmaGap Completes $634,210 Private Placement	TSXV:GAP	Pharmagap Inc.
2011/11/29	05 : 48	Marketwired	PharmaGap Completes Initial Closing of Private Placement	TSXV:GAP	Pharmagap Inc.
2011/11/25	22 : 00	Marketwired	PharmaGap Liposomal Formulations Achieve Key Milestones for Clinical Trials	TSXV:GAP	Pharmagap Inc.
2011/11/15	22 : 00	Marketwired	PharmaGap Announces Start of Definitive Animal Efficacy Study Required to Proceed to Clinical Trials	TSXV:GAP	Pharmagap Inc.
2011/10/27	21 : 00	Marketwired	PharmaGap Sets Time for in Vivo Tests	TSXV:GAP	Pharmagap Inc.
2011/10/24	21 : 00	Marketwired	PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials	TSXV:GAP	Pharmagap Inc.
2011/10/22	05 : 00	Marketwired	PharmaGap Completes Placement of Equity Units	TSXV:GAP	Pharmagap Inc.
2011/10/22	05 : 00	Marketwired Canada	PharmaGap Completes Placement of Equity Units	TSXV:GAP	Pharmagap Inc.
2011/10/19	21 : 00	Marketwired	PharmaGap Completes Manufacturer Site Audits Required for Clinical Trial Submission	TSXV:GAP	Pharmagap Inc.
2011/10/03	21 : 38	Marketwired	PharmaGap Files Provisional Patent Application for Liposomal Formulations of GAP-107B8	TSXV:GAP	Pharmagap Inc.
2011/09/30	23 : 00	Marketwired	PharmaGap to Host Investor Conference Call	TSXV:GAP	Pharmagap Inc.
2011/09/29	21 : 43	Marketwired	PharmaGap Adds to Patent Portfolio For GAP-107B8 Cancer Drug; Expands Claims	TSXV:GAP	Pharmagap Inc.
2011/09/22	21 : 44	Marketwired	PharmaGap Completes Initial Close of Private Placement	TSXV:GAP	Pharmagap Inc.